Phenotypic synergy testing of ceftazidime-avibactam with aztreonam in a university hospital having high number of metallobetalactamase producing bacteria.

Chinmoy SahuSourav PalSangram Singh PatelSanjay SinghShreyas GutteUjjala Ghoshal

Published in: Infectious diseases (London, England) (2020)

Ceftazidime-avibactam and aztreonam rapid synergy testing will be highly beneficial in treatment of infections by metallobetalactamase producing resistant bacteria, especially K. pneumoniae and P. aeruginosa.

Keyphrases

gram negative
multidrug resistant
klebsiella pneumoniae
escherichia coli
loop mediated isothermal amplification
replacement therapy